Opioid-Refractory Pain

Opioid refractory pain is chronic pain that does not respond to standard opioid treatment. Refractory pain is somewhat common in cancer therapy and occurs in around 10-20% of patients.

Quick Answer

What it is

Opioid refractory pain is chronic pain that does not respond to standard opioid treatment. Refractory pain is somewhat common in cancer therapy and occurs in around 10-20% of patients.

Key findings

  • Grade C: Analgesic Use (Cannabis)
  • Grade N/A: Depression Symptoms (Cannabis)
  • Grade N/A: Pain (Cannabis)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Opioid-Refractory Pain

  • Supplements Studied:1
  • Research Trials:1
  • Total Participants:360
  • Top Supplement:Cannabis (C)
1 trials
360 ppts
1 supps · 4 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Limited Evidence

Primary Stack (Tier 1)

600-1200mg daily in divided doses

Endocannabinoid-like compound; anti-inflammatory; analgesic through multiple mechanisms

10 studies | 800 participants
600-1200mg daily

Antioxidant; effective for neuropathic pain; reduces nerve damage

12 studies | 1,000 participants

Supporting Stack (Tier 2)

400-600mg daily

NMDA receptor modulator; may reduce central sensitization; helps with muscle pain

8 studies | 500 participants
500-1500mg daily with enhanced absorption formulation

Anti-inflammatory; modulates multiple pain pathways; well-tolerated

10 studies | 600 participants
2-4g EPA+DHA daily

Anti-inflammatory; reduces pro-inflammatory mediators; supports nerve health

8 studies | 500 participants
2000-4000 IU daily (higher if deficient)

Deficiency common in chronic pain; correction may reduce pain levels

10 studies | 600 participants
300-500mg standardized extract three times daily

Anti-inflammatory; inhibits 5-lipoxygenase; may help with various pain conditions

6 studies | 300 participants

How It Works

Opioid-refractory pain refers to chronic pain that does not respond adequately to opioid medications, or where opioids cannot be used due to side effects, risks, or other factors. This is increasingly recognized as a distinct management challenge.

WHY PAIN MAY NOT RESPOND TO OPIOIDS:

Opioid-induced hyperalgesia: Opioids themselves can increase pain sensitivity
Central sensitization: Nervous system becomes hypersensitive
Neuropathic pain: Nerve damage responds poorly to opioids
Tolerance: Decreasing effectiveness over time
Psychological factors: Depression, anxiety, catastrophizing
Structural factors: Ongoing tissue damage

TYPES OF PAIN LESS RESPONSIVE TO OPIOIDS:

Neuropathic pain (nerve damage)
Central sensitization syndromes (fibromyalgia, CRPS)
Cancer-related neuropathic pain
Phantom limb pain
Post-surgical chronic pain

MULTIMODAL APPROACH IS KEY:

Non-Opioid Medications:

Antidepressants (duloxetine, amitriptyline)
Anticonvulsants (gabapentin, pregabalin)
NMDA antagonists (ketamine, memantine)
Topical agents (lidocaine, capsaicin)

Interventional Options:

Nerve blocks
Spinal cord stimulation
Intrathecal drug delivery
Ablative procedures

Non-Pharmacological:

Physical therapy
Cognitive behavioral therapy for pain
Acceptance and commitment therapy
Mindfulness-based stress reduction
Exercise
Acupuncture
TENS

* PEA is a well-studied alternative with good evidence for chronic pain.

* Alpha-lipoic acid is particularly helpful for neuropathic pain.

* Magnesium may help reduce central sensitization.

Expected timeline: Multimodal approaches require weeks to months to optimize. Supplements may provide additional modest benefit.

Generated from peer-reviewed researchSchema v2.0

Supplements for Opioid-Refractory Pain

Sorted by strength of evidence

Detailed Outcomes

C
Analgesic Use
Small Decrease
1 study
smallImproves
?
Depression Symptoms
1 study
Improves
?
Pain
1 study
Improves
?
Sleep Quality
1 study
Improves

Research Citations (85)

Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study
PMID: 32075958
1 -tetrahydrocannabinol, synhexyl and marijuana extract administered orally in man: catecholamine excretion, plasma cortisol levels and platelet serotonin content
PMID: 5523370
Acute effects of natural and synthetic cannabis compounds on prolactin levels in human males
PMID: 6320226
The effects of smoked marijuana on metabolism and respiratory control
PMID: 367234
Effect of acute Δ9-tetrahydrocannabinol administration on subjective and metabolic hormone responses to food stimuli and food intake in healthy humans: a randomized, placebo-controlled study
PMID: 30949710
Explorative Placebo-Controlled Double-Blind Intervention Study with Low Doses of Inhaled Δ9-Tetrahydrocannabinol and Cannabidiol Reveals No Effect on Sweet Taste Intensity Perception and Liking in Humans
PMID: 28861511
Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients
PMID: 12412840
A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men
PMID: 22133305
Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial
PMID: 18688212
Acute and residual mood and cognitive performance of young adults following smoked cannabis
PMID: 32360692

Related Conditions

Weight Loss & Maintenance

1 shared supplement · 433 outcomes

This goal refers to people with a BMI >25 attempting to reach/maintain their ideal weight. While interventions that work for people with a BMI >25 may also work for people with a lower BMI, the context is often sufficiently different that this isn't assured.

Type 2 Diabetes

1 shared supplement · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Tourette Syndrome

1 shared supplement · 5 outcomes

Tourette syndrome (TS) is a neurological disorder characterized by sudden, repetitive, rapid, and unwanted movements or vocal sounds called tics.

Tobacco Use Disorder

1 shared supplement · 2 outcomes

Tobacco use disorder is a condition involving a dependence on the use of nicotine-containing tobacco products like cigarettes. It involves compulsive cravings for tobacco and cessation of use is very difficult.

Stable Angina

1 shared supplement · 15 outcomes

Angina is the term used to describe chest pain related to acute (e.g., heart attack) or chronic (e.g., stable angina) heart disease. It may feel like a crushing sensation in the chest and could radiate to the shoulders or jaw.

Smoking Behavior

1 shared supplement · 2 outcomes

Smoking behavior refers to individual aspects of smoking that include frequency of daily smoking, timing of one’s first daily cigarette, and characteristics of the actual act of smoking like depth of inhalation, puff duration, and the amount of smoke in a puff.

Sleep Health

1 shared supplement · 84 outcomes

Sleep health encompasses a holistic view of sleep that includes sleep regularity, sleep timing, sleep quality, sleep duration, and satisfaction with one’s sleep.

Sickle Cell Disease

1 shared supplement · 3 outcomes

Sickle cell disease (also known as sickle cell anemia) is a blood disorder that causes red blood cells to be formed into a crescent shape, which results in decreased blood flow and oxygenation. People with sickle cell disease usually experience chronic pain and fatigue.